Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Antonelli

Showing results (711-720 of 858) with videos related to

Pageof 86
Sort By:
Arab Journal of Urology|October 2, 2024
The 2012 Briganti nomogram predicts disease progression after surgery in high-risk prostate cancer patientsAntonio Benito Porcaro, Andrea Panunzio, Rossella Orlando, et al.
Urologia|May 24, 2021
The microbiological profile of patients with Fournier's gangrene: A retrospective multi-institutional cohort studyChiara Cipriani, Valerio Iacovelli, Marco Sandri, et al.
International Urology and Nephrology|March 30, 2024
Tumor upgrading among very favorable intermediate-risk prostate cancer patients treated with robot-assisted radical prostatectomy: how can it impact the clinical course?Antonio Benito Porcaro, Alberto Bianchi, Andrea Panunzio, et al.
Minerva Urology and Nephrology|January 13, 2021
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational studyCarlotta Palumbo, Alessio Bruni, Alessandro Antonelli, et al.
The New England Journal of Medicine|May 4, 2017
Teprotumumab for Thyroid-Associated OphthalmopathyTerry J Smith, George J Kahaly, Daniel G Ezra, et al.
Cancers|April 14, 2025
Perioperative and Mid-Term Oncological and Functional Outcomes After Partial Nephrectomy for Entirely Endophytic Renal Tumors: A Prospective Multicenter Observational Study (The RECORD2 Project)Fabrizio Di Maida, Andrea Mari, Daniele Amparore, et al.
International Journal of Environmental Research and Public Health|December 11, 2022
MRI-Derived Apparent Diffusion Coefficient of Peri-Prostatic Adipose Tissue Is a Potential Determinant of Prostate Cancer Aggressiveness in Preoperative Setting: A Preliminary ReportAlessandro Tafuri, Andrea Panunzio, Federico Greco, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|April 17, 2020
Comprehensive long-term assessment of outcomes following robot-assisted partial nephrectomy for renal cell carcinoma: the ROMe's achievement and its predicting nomogramAldo Brassetti, Umberto Anceschi, Riccardo Bertolo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 3, 2020
Predicting positive surgical margins in partial nephrectomy: A prospective multicentre observational study (the RECORd 2 project)Riccardo Schiavina, Andrea Mari, Lorenzo Bianchi, et al.
Ophthalmology|October 24, 2021
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X StudyRaymond S Douglas, George J Kahaly, Shoaib Ugradar, et al.
Pageof 86

Showing results (711-720 of 858) with videos related to

Sort By:
Pageof 86
Arab Journal of Urology|October 2, 2024
The 2012 Briganti nomogram predicts disease progression after surgery in high-risk prostate cancer patientsAntonio Benito Porcaro, Andrea Panunzio, Rossella Orlando, et al.
Urologia|May 24, 2021
The microbiological profile of patients with Fournier's gangrene: A retrospective multi-institutional cohort studyChiara Cipriani, Valerio Iacovelli, Marco Sandri, et al.
International Urology and Nephrology|March 30, 2024
Tumor upgrading among very favorable intermediate-risk prostate cancer patients treated with robot-assisted radical prostatectomy: how can it impact the clinical course?Antonio Benito Porcaro, Alberto Bianchi, Andrea Panunzio, et al.
Minerva Urology and Nephrology|January 13, 2021
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational studyCarlotta Palumbo, Alessio Bruni, Alessandro Antonelli, et al.
The New England Journal of Medicine|May 4, 2017
Teprotumumab for Thyroid-Associated OphthalmopathyTerry J Smith, George J Kahaly, Daniel G Ezra, et al.
Cancers|April 14, 2025
Perioperative and Mid-Term Oncological and Functional Outcomes After Partial Nephrectomy for Entirely Endophytic Renal Tumors: A Prospective Multicenter Observational Study (The RECORD2 Project)Fabrizio Di Maida, Andrea Mari, Daniele Amparore, et al.
International Journal of Environmental Research and Public Health|December 11, 2022
MRI-Derived Apparent Diffusion Coefficient of Peri-Prostatic Adipose Tissue Is a Potential Determinant of Prostate Cancer Aggressiveness in Preoperative Setting: A Preliminary ReportAlessandro Tafuri, Andrea Panunzio, Federico Greco, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|April 17, 2020
Comprehensive long-term assessment of outcomes following robot-assisted partial nephrectomy for renal cell carcinoma: the ROMe's achievement and its predicting nomogramAldo Brassetti, Umberto Anceschi, Riccardo Bertolo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 3, 2020
Predicting positive surgical margins in partial nephrectomy: A prospective multicentre observational study (the RECORd 2 project)Riccardo Schiavina, Andrea Mari, Lorenzo Bianchi, et al.
Ophthalmology|October 24, 2021
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X StudyRaymond S Douglas, George J Kahaly, Shoaib Ugradar, et al.
Pageof 86